Arrowhead Pharmaceuticals ARWR
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q2 | 15.80 | -1.26 | -165,550 | -175 | ||
| 2025Q1 | 12.74 | 97.43 | 2.91 | 381,202 | 370 | |
| 2024Q4 | 18.80 | 105.18 | -1.39 | -161,412 | -173 | |
| 2024Q3 | 19.37 | 102.56 | -1.37 | -162,203 | -171 | |
| 2024Q2 | 25.99 | 104.30 | -1.39 | -176,141 | -171 | |
| 2024Q1 | 28.60 | 105.38 | -1.00 | -126,191 | -125 | |
| 2023Q4 | 30.60 | 102.42 | -1.24 | -136,545 | -133 | |
| 2023Q3 | 26.87 | 104.44 | -1.02 | -108,330 | -110 | |
| 2023Q2 | 35.66 | 104.56 | -0.97 | -102,703 | -103 | |
| 2023Q1 | 25.40 | 91.34 | 0.46 | 48,165 | 49 | |
| 2022Q4 | 40.56 | 101.22 | -0.39 | -42,134 | -41 | |
| 2022Q3 | 33.05 | 102.04 | -0.81 | -83,830 | -86 | |
| 2022Q2 | 35.21 | 101.20 | -0.68 | -72,909 | -72 | |
| 2022Q1 | 45.99 | 91.28 | 0.42 | 41,553 | 44 | |
| 2021Q4 | 66.30 | 100.71 | -0.60 | -63,321 | -63 | |
| 2021Q3 | 62.43 | 93.37 | -0.61 | -64,883 | -63 | |
| 2021Q2 | 82.82 | 106.50 | -0.29 | -31,868 | -30 | |
| 2021Q1 | 66.31 | 105.27 | -0.26 | -28,231 | -27 | |
| 2020Q4 | 76.73 | 105.03 | -0.20 | -24,054 | -21 | |
| 2020Q3 | 43.06 | 86.98 | -0.48 | -50,119 | -48 |